Microneedling for Hair Loss.


Journal

Journal of cosmetic dermatology
ISSN: 1473-2165
Titre abrégé: J Cosmet Dermatol
Pays: England
ID NLM: 101130964

Informations de publication

Date de publication:
Jan 2022
Historique:
revised: 10 09 2021
received: 09 06 2021
accepted: 30 09 2021
pubmed: 30 10 2021
medline: 29 12 2021
entrez: 29 10 2021
Statut: ppublish

Résumé

Microneedling is a relatively novel therapeutic modality introduced in the 1990s where small, fine needles are used to create micro punctures in the skin. It is a minimally invasive procedure used for various dermatological conditions, including androgenetic alopecia (AGA). We comprehensively summarize the literature regarding microneedling in dermatology. We performed linear multivariable regressions to synthesize evidence from the clinical trials that investigated the efficacy of microneedling for AGA. Studies eligible for quantitative analyses were assessed for evidence quality. The exact mechanism of microneedling action is yet to be determined, with theories that include the wound-healing cascade. Microneedling monotherapy significantly increased total hair count more than topical minoxidil 5% (β = 12.29; p < 0.001). The combination treatment of microneedling with topical 5% minoxidil increased total hair count significantly compared to monotherapy with microneedling (β = 7.63, p < 0.05). Increasing the overall treatment duration of microneedling and reducing the frequency of microneedling sessions may positively influence an increase in total hair count. There are limited studies that investigate microneedling as a monotherapy for hair loss since majority of the trials combine it with other therapies such as topical minoxidil or platelet-rich plasma. While preliminary results look promising, further investigation of microneedling as a monotherapy in larger, randomized controlled trials will help determine its safety and efficacy, and place in treating AGA.

Sections du résumé

BACKGROUND BACKGROUND
Microneedling is a relatively novel therapeutic modality introduced in the 1990s where small, fine needles are used to create micro punctures in the skin. It is a minimally invasive procedure used for various dermatological conditions, including androgenetic alopecia (AGA).
OBJECTIVE AND METHODS OBJECTIVE
We comprehensively summarize the literature regarding microneedling in dermatology. We performed linear multivariable regressions to synthesize evidence from the clinical trials that investigated the efficacy of microneedling for AGA. Studies eligible for quantitative analyses were assessed for evidence quality.
RESULTS RESULTS
The exact mechanism of microneedling action is yet to be determined, with theories that include the wound-healing cascade. Microneedling monotherapy significantly increased total hair count more than topical minoxidil 5% (β = 12.29; p < 0.001). The combination treatment of microneedling with topical 5% minoxidil increased total hair count significantly compared to monotherapy with microneedling (β = 7.63, p < 0.05). Increasing the overall treatment duration of microneedling and reducing the frequency of microneedling sessions may positively influence an increase in total hair count.
CONCLUSION CONCLUSIONS
There are limited studies that investigate microneedling as a monotherapy for hair loss since majority of the trials combine it with other therapies such as topical minoxidil or platelet-rich plasma. While preliminary results look promising, further investigation of microneedling as a monotherapy in larger, randomized controlled trials will help determine its safety and efficacy, and place in treating AGA.

Identifiants

pubmed: 34714971
doi: 10.1111/jocd.14525
doi:

Substances chimiques

Minoxidil 5965120SH1

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

108-117

Informations de copyright

© 2021 Wiley Periodicals LLC.

Références

Santos Z, Avci P, Hamblin MR. Drug discovery for alopecia: gone today, hair tomorrow. Expert Opin. Drug Discov. 2015;10(3):269-292. 10.1517/17460441.2015.1009892
Unger WP. Planning and organization. In: Unger WP, Shapiro R, Unger R, Unger M, (Eds.). Hair Transplantation. 5th ed. London, UK: Informa Health Care; 2011:106-151.
Cohen IS. Guidelines for hair transplantation in the young patient. Hair Transpl. Forum Int. 2001;11(5):131-133. 10.33589/11.5.131
Gupta AK, Bamimore MA, Foley KA. Efficacy of non-surgical treatments for androgenetic alopecia in men and women: a systematic review with network meta-analyses, and an assessment of evidence quality. J Dermatol Treat. 2020;1-11. 10.1080/09546634.2020.1749547
Singh A, Yadav S. Microneedling: advances and widening horizons. Indian Dermatol Online J. 2016;7(4):244-254. 10.4103/2229-5178.185468
Iriarte C, Awosika O, Rengifo-Pardo M, Ehrlich A. Review of applications of microneedling in dermatology. Clin Cosmet Investig Dermatol. 2017;10:289-298. 10.2147/CCID.S142450
Fernandes D. Minimally invasive percutaneous collagen induction. Oral Maxillofac Surg Clin N Am. 2005;17(1):pp 51-63. 10.1016/j.coms.2004.09.004
Bahuguna A. Micro needling - facts and fictions. Asian J Med Sci. 2013;4(3):1-4. 10.3126/ajms.v4i3.5392
Dermapen vs Derma Roller: Which Is Better?. https://facemedstore.com/blogs/blog/dermapen-vs-derma-roller. Accessed 2021-07-30.
Microneedling Pen vs. Microneedling Roller What’s the Difference?. The Laser and Skin Clinic. https://laserandskin.ie/dermapen-vs-dermaroller-whats-difference/. Accessed 2021-07-30.
Hollins M, McDermott K, Harper D. How does vibration reduce pain? Perception. 2014;43(1):70-84. 10.1068/p7637
Tan MG, Jo CE, Chapas A, Khetarpal S, Dover JS. Radiofrequency microneedling: a comprehensive and critical review. Dermatologic Surgery. 2021;47(6):755-761. 10.1097/DSS.0000000000002972
Orentreich DS, Orentreich N. Subcutaneous incisionless (subcision) surgery for the correction of depressed scars and wrinkles. Dermatol Surg off. Publ Am Soc Dermatol Surg Al. 1995;21(6):543-549. 10.1111/j.1524-4725.1995.tb00259.x
Falabella A, Falanga V. Wound Healing. In: Freinkel R, Woodley D, (Eds.). The Biology of the Skin; CRC Press, 2001; pp 281-297.
de Andrade Lima E, de Andrade Lima M, Takano D. Microneedling: experimental study and classification of the resulting injury. Surg Cosmet Dermatol. 2013;5(2):110-114.
Fabbrocini G, Fardella N, Monfrecola A, Proietti I, Innocenzi D. Acne scarring treatment using skin needling. Clin Exp Dermatol. 2009;34(8):874-879. 10.1111/j.1365-2230.2009.03291.x
Majid I, Sheikh G. Microneedling and Its applications in dermatology. PRIME. 2014. https://www.prime-journal.com/microneedling-and-its-applications-in-dermatology/
El-Domyati M, Barakat M, Awad S, Medhat W, El-Fakahany H, Farag H. Multiple microneedling sessions for minimally invasive facial rejuvenation: an objective assessment. Int J Dermatol. 2015;54(12):1361-1369. 10.1111/ijd.12761
Liebl H, Kloth LC. Skin cell proliferation stimulated by microneedles. J Am Coll Clin Wound Spec. 2012;4(1):2-6. 10.1016/j.jccw.2012.11.001
Bariya SH, Gohel MC, Mehta TA, Sharma OP. Microneedles: an emerging transdermal drug delivery system. J Pharm Pharmacol. 2012;64(1):11-29. 10.1111/j.2042-7158.2011.01369.x
Sasaki GH. Review of human hair follicle biology: dynamics of niches and stem cell regulation for possible therapeutic hair stimulation for plastic surgeons. Aesthetic Plast Surg. 2019;43(1):253-266. 10.1007/s00266-018-1248-1
Hsu Y-C, Pasolli HA, Fuchs E. Dynamics between stem cells, niche, and progeny in the hair follicle. Cell. 2011;144(1):92-105. 10.1016/j.cell.2010.11.049
Chen D, Jarrell A, Guo C, Lang R, Atit R. Dermal β-catenin activity in response to epidermal wnt ligands is required for fibroblast proliferation and hair follicle initiation. Dev Camb Engl. 2012;139(8):1522-1533. 10.1242/dev.076463
Plikus MV, Mayer JA, de la Cruz D, et al. Cyclic dermal BMP signalling regulates stem cell activation during hair regeneration. Nature. 2008;451(7176):340-344. 10.1038/nature06457
Otberg N, Finner AM, Shapiro J. Androgenetic alopecia. Endocrinol Metab Clin North Am. 2007;36(2):379-398. 10.1016/j.ecl.2007.03.004
Hibberts NA, Howell AE, Randall VA. Balding hair follicle dermal papilla cells contain higher levels of androgen receptors than those from non-balding scalp. J Endocrinol. 1998;156(1):59-65.
Leirós GJ, Attorresi AI, Balañá ME. Hair follicle stem cell differentiation is inhibited through cross-talk between Wnt/β-catenin and androgen signalling in dermal papilla cells from patients with androgenetic alopecia. Br J Dermatol. 2012;166(5):1035-1042. 10.1111/j.1365-2133.2012.10856.x
Dhurat R, Sukesh M, Avhad G, Dandale A, Pal A, Pund P. A randomized evaluator blinded study of effect of microneedling in androgenetic alopecia: a pilot study. Int J Trichology. 2013;5(1):6-11. 10.4103/0974-7753.114700
Bonati LM, Epstein GK, Strugar TL. Microneedling in all skin types: a review. J Drugs Dermatol JDD. 2017;16(4):308-313.
Shorter K, Farjo NP, Picksley SM, Randall VA. Human hair follicles contain two forms of ATP-sensitive potassium channels, only one of which is sensitive to minoxidil. FASEB J Off Publ Fed Am Soc Exp Biol. 2008;22(6):1725-1736. 10.1096/fj.07-099424
Fertig RM, Gamret AC, Cervantes J, Tosti A. Microneedling for the treatment of hair loss? J Eur Acad Dermatol Venereol JEADV. 2018;32(4):564-569. 10.1111/jdv.14722
Sharma A, Surve R, Dhurat R, et al. Microneedling improves minoxidil response in androgenetic alopecia patients by upregulating follicular sulfotransferase enzymes. J Biol Regul Homeost Agents. 2020;34(2):659-661. 10.23812/19-385-L-51
Kim YS, Jeong KH, Kim JE, Woo YJ, Kim BJ, Kang H. Repeated microneedle stimulation induces enhanced hair growth in a murine model. Ann Dermatol. 2016;28(5):586-592. 10.5021/ad.2016.28.5.586
Faghihi G, Nabavinejad S, Mokhtari F, Fatemi Naeini F, Iraji F. Microneedling in androgenetic alopecia; comparing two different depths of microneedles. J Cosmet Dermatol. 2021;20(4):1241-1247. 10.1111/jocd.13714
Aggarwal K, Gupta S, Jangra RS, Mahendra A, Yadav A, Sharma A. Dermoscopic assessment of microneedling alone versus microneedling with platelet-rich plasma in cases of male pattern alopecia: a split-head comparative study. Int J Trichology. 2020;12(4):156-163. 10.4103/ijt.ijt_64_20
Bao L, Zong H, Fang S, Zheng L, Li Y. Randomized trial of electrodynamic microneedling combined with 5% minoxidil topical solution for treating androgenetic alopecia in chinese males and molecular mechanistic study of the involvement of the wnt/β-catenin signaling pathway. J Dermatol Treat. 2020;1-11. 10.1080/09546634.2020.1770162
Bao L, Gong L, Guo M, et al. Randomized trial of electrodynamic microneedle combined with 5% minoxidil topical solution for the treatment of Chinese male androgenetic alopecia. J Cosmet Laser Ther off Publ Eur Soc Laser Dermatol. 2020;22(1):1-7. 10.1080/14764172.2017.1376094
Kumar M, Inamadar A, Palit A. A randomized controlled, single-observer blinded study to determine the efficacy of topical minoxidil plus microneedling versus topical minoxidil alone in the treatment of androgenetic alopecia. J Cutan Aesthetic Surg. 2018;11(4):211-216. 10.4103/JCAS.JCAS_130_17
Lee YB, Eun YS, Lee JH, et al. Effects of topical application of growth factors followed by microneedle therapy in women with female pattern hair loss: a pilot study. J Dermatol. 2013;40(1):81-83. 10.1111/j.1346-8138.2012.01680.x
Sohng C, Lee EH, Woo SK, et al. Usefulness of home-use microneedle devices in the treatment of pattern hair loss. J Cosmet Dermatol. 2021;20(2):591-596. 10.1111/jocd.13540
Yu CQ, Zhang H, Guo ME, et al. Combination therapy with topical minoxidil and nano-microneedle-assisted fibroblast growth factor for male androgenetic alopecia: a randomized controlled trial in Chinese patients. Chin Med J (engl.). 2021;134(7):851-853. 10.1097/CM9.0000000000001195
Higgins JPT, Altman DG, Gøtzsche PC, et al. The cochrane collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. 10.1136/bmj.d5928
Gowda A, Healey B, Ezaldein H, Merati M. A systematic review examining the potential adverse effects of microneedling. J Clin Aesthetic Dermatol. 2021;14(1):45-54.
Pahwa M, Pahwa P, Zaheer A. “Tram track effect” after treatment of acne scars using a microneedling device. Dermatol Surg off Publ Am Soc Dermatol Surg Al. 2012;38(7 Pt 1):1107-1108. 10.1111/j.1524-4725.2012.02441.x

Auteurs

Aditya K Gupta (AK)

Mediprobe Research Inc., London, ON, Canada.
Faculty of Medicine, University of Toronto, Toronto, ON, Canada.

Emma M Quinlan (EM)

Mediprobe Research Inc., London, ON, Canada.

Maanasa Venkataraman (M)

Mediprobe Research Inc., London, ON, Canada.

Mary A Bamimore (MA)

Mediprobe Research Inc., London, ON, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH